European Prostate Cancer Awareness Day: CLEAR-PC and PRAISE-U promote informed early detection

On European Prostate Cancer Awareness Day (EPAD), held in Brussels from 5 to 7 November 2026, patients, citizens, healthcare professionals, researchers and policymakers gathered to raise awareness of prostate cancer and promote a better understanding of the disease.

CLEAR-PC took part in an event organised by the European project PRAISE-U at the European Multidisciplinary Congress on Urological Cancers (EMUC26), where the project’s results were presented.

During the event, Lionne Venderbos (Erasmus MC), a researcher involved in both projects, presented the CLEAR-PC initiative on prostate cancer health literacy, highlighting how the two projects complement each other in promoting smarter, more effective and patient-centred early detection strategies.

While PRAISE-U focuses on developing and implementing risk-adapted pathways for prostate cancer early detection, using tools such as PSA testing, risk assessment tools and MRI to reduce unnecessary biopsies and overdiagnosis, CLEAR-PC addresses another essential aspect: ensuring that men have the knowledge and understanding needed to make informed decisions about screening.

The collaboration between the projects is built around a shared recognition that effective early detection requires not only appropriate clinical pathways but also well-informed individuals who can actively participate in decisions about their health.

Lionne’s presentation outlined four important aspects:

  • Empowering informed men: developing co-designed tools to support patients at every stage of the clinical pathway.
  • Promoting equity: reaching populations with lower health and digital health literacy to ensure that everyone can access and understand relevant information.
  • Testing solutions in real-world settings: piloting and validating strategies within real healthcare systems.
  • Evaluating impact together: integrating informed-choice indicators into screening performance measures.

In line with European Union recommendations and European Association of Urology guidelines, early testing should be offered to men who are adequately informed and supported in their decisions.

By combining PRAISE-U’s work on risk-adapted early detection pathways with CLEAR-PC’s focus on health literacy and shared decision-making, the projects aim to make prostate cancer early detection more accessible, equitable and patient-centred across Europe. Because effective screening requires informed men.

The EPAD is an annual initiative, supported by Europa Uomo and the European Association of Urologists, held to raise awareness, improve early detection, and support risk-based screening and treatment for prostate cancer across Europe.